{"title":"The mixed era of stereotactic radiosurgery and radiotherapy","authors":"Kawngwoo Park","doi":"10.52662/jksfn.2021.00038","DOIUrl":null,"url":null,"abstract":"Since the introduction of radiosurgery by Leksell in 1951 [1], stereotactic radiosurgery (SRS) with delivery of a high dose of radiation in a single session has been used for the treatment of lesions in the brain and spine [2]. He developed the first commercially available dedicated radiosurgical device called the “Gamma Knife” (GK) in 1968. This machine made it possible to precisely deliver a single, large dose of highly conformal radiation to any number of intracranial sites using 201 fixed cobalt sources aimed at a center point. Since he coined the term “stereotactic radiosurgery”, 330 centers of GK radiosurgery in 54 countries currently treat a total of 80,000 new patients each year. Through approximately 70 years of SRS experience that began with GK radiosurgery, the role of radiosurgery has expanded to a wide variety of benign brain tumors, arteriovenous malformations, functional disorders (trigeminal neuralgia, movement disorder, epilepsy, and pain), and malignant brain tumors. On the other hand, radiation oncologists were unfamiliar with SRS such as highdose irradiation. They did not believe in the effectiveness of high-dose irradiation of the body from a radiobiological perspective, and were even concerned that radiation side effects would increase. These physicians had been treating with fractionated radiotherapy (RT) to reduce radiation side effects and planning target volume margins to minimize treatment uncertainty, as they were in an era of undeveloped imaging techniques. However, advances in radiotherapeutic and radioimaging technology have eliminated uncertainty in precision and high-dose radiation therapy. Subsequently, stereotactic body radiotherapy (SBRT) was derived from SRS with improvements in radiation technology, using a small number of fractions with a high degree of precision within the body, unlike traditional fractionated RT [3]. The terms “SRS” and “SBRT” were used for central nervous system (CNS) and non-CNS anatomic sites, respectively, and in both cases involve the delivery of a Received: May 25, 2021 Accepted: June 9, 2021","PeriodicalId":193825,"journal":{"name":"Journal of the Korean Society of Stereotactic and Functional Neurosurgery","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Korean Society of Stereotactic and Functional Neurosurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52662/jksfn.2021.00038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Since the introduction of radiosurgery by Leksell in 1951 [1], stereotactic radiosurgery (SRS) with delivery of a high dose of radiation in a single session has been used for the treatment of lesions in the brain and spine [2]. He developed the first commercially available dedicated radiosurgical device called the “Gamma Knife” (GK) in 1968. This machine made it possible to precisely deliver a single, large dose of highly conformal radiation to any number of intracranial sites using 201 fixed cobalt sources aimed at a center point. Since he coined the term “stereotactic radiosurgery”, 330 centers of GK radiosurgery in 54 countries currently treat a total of 80,000 new patients each year. Through approximately 70 years of SRS experience that began with GK radiosurgery, the role of radiosurgery has expanded to a wide variety of benign brain tumors, arteriovenous malformations, functional disorders (trigeminal neuralgia, movement disorder, epilepsy, and pain), and malignant brain tumors. On the other hand, radiation oncologists were unfamiliar with SRS such as highdose irradiation. They did not believe in the effectiveness of high-dose irradiation of the body from a radiobiological perspective, and were even concerned that radiation side effects would increase. These physicians had been treating with fractionated radiotherapy (RT) to reduce radiation side effects and planning target volume margins to minimize treatment uncertainty, as they were in an era of undeveloped imaging techniques. However, advances in radiotherapeutic and radioimaging technology have eliminated uncertainty in precision and high-dose radiation therapy. Subsequently, stereotactic body radiotherapy (SBRT) was derived from SRS with improvements in radiation technology, using a small number of fractions with a high degree of precision within the body, unlike traditional fractionated RT [3]. The terms “SRS” and “SBRT” were used for central nervous system (CNS) and non-CNS anatomic sites, respectively, and in both cases involve the delivery of a Received: May 25, 2021 Accepted: June 9, 2021
自1951年Leksell引入放射外科以来,立体定向放射外科(SRS)在单次高剂量放射治疗中已被用于治疗脑和脊柱病变。1968年,他开发了第一个商用专用放射外科设备,称为“伽玛刀”(GK)。这台机器可以使用201个固定的钴源瞄准一个中心点,精确地向任何数量的颅内部位提供单次大剂量的高适形辐射。自从他创造了“立体定向放射外科”一词以来,目前54个国家的330个GK放射外科中心每年总共治疗8万名新患者。从GK放射外科开始,经过大约70年的SRS经验,放射外科的作用已经扩展到各种良性脑肿瘤、动静脉畸形、功能障碍(三叉神经痛、运动障碍、癫痫和疼痛)和恶性脑肿瘤。另一方面,放射肿瘤学家对高剂量辐射等SRS并不熟悉。从放射生物学的角度来看,他们不相信高剂量辐射对人体的有效性,甚至担心辐射的副作用会增加。这些医生一直使用分割放疗(RT)治疗,以减少放射副作用,并规划靶体积边界,以最大限度地减少治疗的不确定性,因为他们处于一个成像技术不发达的时代。然而,放射治疗和放射成像技术的进步已经消除了精确和高剂量放射治疗的不确定性。随后,立体定向全身放疗(stereotactic body radiation, SBRT)在放射技术改进的基础上衍生而来,与传统的分步放疗[3]不同,它在体内使用少量的分步放疗,精确度高。术语“SRS”和“SBRT”分别用于中枢神经系统(CNS)和非中枢神经系统解剖部位,在这两种情况下均涉及交付一份接收日期:2021年5月25日接收日期:2021年6月9日